NutriBand (NTRB) Other financing activities (2022 - 2025)

NutriBand (NTRB) posted Other financing activities of $75000.0 for Q4 2025, down 98.01% sequentially from $3.8 million in Q1 2022.

NutriBand (NTRB) Other financing activities (2022 - 2025) Analysis & Trends

NutriBand has reported Other financing activities for 2 years, with the latest figure at $75000.0 in Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $75000.0 in Q4 2025, while the trailing twelve-month figure through Jan 2026 was $75000.0 (changed N/A YoY) and the FY2026 annual result came in at $119206.0, changed N/A from the prior year.
Other financing activities retreated to $75000.0 in Q4 2025 per NTRB's latest filing, from $3.8 million in the prior quarter.
Over five years, Other financing activities peaked at $3.8 million in Q1 2022 and troughed at $75000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.81 Bn	130.96 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.07 Bn	78.08 Bn	3.93 Bn
3	Argenx Se	65.47 Bn	60.29 Bn	1.37 Bn
4	Moderna	55.64 Bn	50.50 Bn	52.00 Mn
5	BeOne Medicines	41.99 Bn	36.89 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.68 Bn	28.37 Bn	992.69 Mn
7	BioNTech SE	27.69 Bn	9.29 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.36 Bn	26.52 Bn	-
10	NutriBand	53.36 Mn	49.36 Mn	196,801.00

Download Data